Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacripep in Dry Eye Associated With Primary Sjögren's Syndrome
NCT03226444Phase 2Completed
- Sponsor
- TearSolutions, Inc.
- Start
- Jun 2017
- Primary completion
- Dec 2019
- Modality
- Recombinant Proteins and Enzymes, Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of Lacripep in dry eye syndrome (DED), sponsored by TearSolutions, Inc.. Started Jun 2017; status: completed.
02
Drugs
Lacripep
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT03226444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03226444.